These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11012891)
1. CD59 protects rat kidney from complement mediated injury in collaboration with crry. Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891 [TBL] [Abstract][Full Text] [Related]
2. Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement. Nomura A; Nishikawa K; Yuzawa Y; Okada H; Okada N; Morgan BP; Piddlesden SJ; Nadai M; Hasegawa T; Matsuo S J Clin Invest; 1995 Nov; 96(5):2348-56. PubMed ID: 7593622 [TBL] [Abstract][Full Text] [Related]
4. Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). Jha P; Sohn JH; Xu Q; Wang Y; Kaplan HJ; Bora PS; Bora NS J Immunol; 2006 Jun; 176(12):7221-31. PubMed ID: 16751365 [TBL] [Abstract][Full Text] [Related]
5. Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation. Mizuno T; Mizuno M; Morgan BP; Noda Y; Yamada K; Okada N; Yuzawa Y; Matsuo S; Ito Y Nephrol Dial Transplant; 2011 Jun; 26(6):1821-30. PubMed ID: 21098015 [TBL] [Abstract][Full Text] [Related]
6. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244 [TBL] [Abstract][Full Text] [Related]
8. In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats. Matsuo S; Ichida S; Takizawa H; Okada N; Baranyi L; Iguchi A; Morgan BP; Okada H J Exp Med; 1994 Nov; 180(5):1619-27. PubMed ID: 7525834 [TBL] [Abstract][Full Text] [Related]
9. Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement. Hanna S; Spiller O; Linton SM; Mead RJ; Morgan B Eur J Immunol; 2002 Feb; 32(2):502-9. PubMed ID: 11828367 [TBL] [Abstract][Full Text] [Related]
10. Role of CD59 in experimental glomerulonephritis in rats. Matsuo S; Nishikage H; Yoshida F; Nomura A; Piddlesden SJ; Morgan BP Kidney Int; 1994 Jul; 46(1):191-200. PubMed ID: 7523753 [TBL] [Abstract][Full Text] [Related]
11. Binding of human and rat CD59 to the terminal complement complexes. Lehto T; Morgan BP; Meri S Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722 [TBL] [Abstract][Full Text] [Related]
12. Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. He C; Imai M; Song H; Quigg RJ; Tomlinson S J Immunol; 2005 May; 174(9):5750-7. PubMed ID: 15843577 [TBL] [Abstract][Full Text] [Related]
14. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Miwa T; Zhou L; Hilliard B; Molina H; Song WC Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227 [TBL] [Abstract][Full Text] [Related]
15. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580 [TBL] [Abstract][Full Text] [Related]
16. Activation of complement components and reduced regulator expression in alcohol-induced liver injury in the rat. Järveläinen HA; Väkevä A; Lindros KO; Meri S Clin Immunol; 2002 Oct; 105(1):57-63. PubMed ID: 12483994 [TBL] [Abstract][Full Text] [Related]
17. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Väkevä A; Morgan BP; Tikkanen I; Helin K; Laurila P; Meri S Am J Pathol; 1994 Jun; 144(6):1357-68. PubMed ID: 7515561 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59. Mizuno M; Nishikawa K; Morgan BP; Matsuo S Clin Exp Immunol; 2000 Feb; 119(2):368-75. PubMed ID: 10632677 [TBL] [Abstract][Full Text] [Related]
19. Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris. Quigg RJ; He C; Hack BK; Alexander JJ; Morgan BP Immunology; 2000 Jan; 99(1):46-53. PubMed ID: 10651940 [TBL] [Abstract][Full Text] [Related]